13491-41-3

Basic information

• Product Name: 4-(hydroxyamino)-1-pentofuranosylpyrimidin-2(1H)-one
• CAS NO: 13491-41-3
• Molecular Formula: C₉H₁₃N₃O₆
• Molecular Weight: 259.216
• Mol File: 13491-41-3.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 576.1°C at 760 mmHg
• Flash Point: 302.2°C
• Density: 1.93g/cm³
• Vapor Pressure: 1.14E-15mmHg at 25°C
• Refractive Index: 1.753
• CAS DataBase Reference: 4-(hydroxyamino)-1-pentofuranosylpyrimidin-2(1H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(hydroxyamino)-1-pentofuranosylpyrimidin-2(1H)-one(13491-41-3)
• EPA Substance Registry System: 4-(hydroxyamino)-1-pentofuranosylpyrimidin-2(1H)-one(13491-41-3)

Safety Data

• Hazardous Substances Data: 13491-41-3(Hazardous Substances Data)

Upstream product

• 87418-88-0 1-[(2R,3S,4R,5R)-3,4-Bis-(tert-butyl-dimethyl-silanyloxy)-5-(tert-butyl-dimethyl-silanyloxymethyl)-tetrahydro-furan-2-yl]-1H-pyrimidine-2,4-dione 
• 3083-77-0 araU 
• 82855-62-7 4-(1,2,4-triazol-1-yl)-1-(2',3',5'-tri-O-acetyl-β-D-arabinofuranosyl)pyrimidine-2(1H)one 

Relevant articles and documents

N4-HYDROXYCYTIDINE AND DERIVATIVES AND ANTI-VIRAL USES RELATED THERETO

This disclosure relates to certain N4-hydroxycytidine derivatives, compositions, and methods related thereto. In certain embodiments, the disclosure relates to the treatment or prophylaxis of a Zika virus infection.

Anti-HCV nucleoside derivatives

The present invention comprises novel and known purine and pyrimidine nucleoside derivatives which have been discovered to be active against hepatitis C virus (HCV). The use of these derivatives for the treatment of HCV infection is claimed as are the novel nucleoside derivatives disclosed herein.

Pyrimidine nucleosides. 6. Syntheses and anticancer activities of N4 substituted 2,2' anhydronucleosides

Some derivatives of N4 substituted 2,2' cyclo araC [N4 hydroxy, N4 methoxy, N4 methyl, and N4phenyl] which are potential carcinostatic nucleosides were prepared by introducing the 2,2' anhydro linkage